Christine Carberry
2017
In 2017, Christine Carberry earned a total compensation of $1.8M as Chief Operating Officer at Keryx Biopharmaceuticals.
Compensation breakdown
| Bonus | $14,630 |
|---|---|
| Non-Equity Incentive Plan | $146,300 |
| Option Awards | $729,742 |
| Salary | $357,718 |
| Stock Awards | $511,700 |
| Other | $8,019 |
| Total | $1,768,109 |
Carberry received $729.7K in option awards, accounting for 41% of the total pay in 2017.
Carberry also received $14.6K in bonus, $146.3K in non-equity incentive plan, $357.7K in salary, $511.7K in stock awards and $8K in other compensation.
Rankings
In 2017, Christine Carberry's compensation ranked 6,118th out of 14,666 executives tracked by ExecPay. In other words, Carberry earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,118 out of 14,666 | 58th |
Division Manufacturing | 2,249 out of 5,772 | 61st |
Major group Chemicals And Allied Products | 710 out of 2,075 | 66th |
Industry group Drugs | 547 out of 1,731 | 68th |
Industry Pharmaceutical Preparations | 430 out of 1,333 | 68th |
Source: SEC filing on May 31, 2018.
Carberry's colleagues
We found four more compensation records of executives who worked with Christine Carberry at Keryx Biopharmaceuticals in 2017.